Clearance Summary
R&D HGB/GLC WHOLE BLOOD CONTROL received FDA 510(k) clearance under submission number K993321, sponsored by R&D Systems, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1999-11-12.
- Submission: K993321
- Applicant / Sponsor: R&D Systems, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.8625
- Decision date: 1999-11-12
Classification & Regulation
This clearance is catalogued under FDA product code GGM and 21 CFR 864.8625, within the Hematology review panel as a Class II device.